With three COVID-19 vaccines on their way, the U.S. Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee will be meeting on December 10, 2020 in an open hearing. Presentations will be made by the first of these, the Pfizer-BioTech COVID-19 Vaccine, for the prevention of COVID-19 in individuals 16 years of age and older.

To be ready, here is a primer with the shortest official FDA summary of the emergency use fast track of the COVID-19 vaccines, from development and approval, through manufacture and quality control standards, to deployment and tracking of reportable events.